ArticlePharmaceuticals (Basel, Switzerland)2025
Network Pharmacology and Experimental Validation Identify Paeoniflorin as a Novel SRC-Targeted Therapy for Castration-Resistant Prostate Cancer.
Meng-Yao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.